Richard I. Feder
Cluj-napoca, CJ, Romania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Challenges in the preclinical design and assessment of CAR-T cells.
Journal: Frontiers in immunology
Published: January 22, 2025
5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity.
Journal: Medicine and pharmacy reports
Published: July 31, 2024
In vivo imaging system (IVIS) therapeutic assessment of tyrosine kinase inhibitor-loaded gold nanocarriers for acute myeloid leukemia: a pilot study.
Journal: Frontiers in pharmacology
Published: February 05, 2024
Current trends in luminescence-based assessment of apoptosis.
Journal: RSC advances
Published: August 25, 2023
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia.
Journal: Journal of cellular and molecular medicine
Published: October 13, 2022
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy.
Journal: Journal of cellular and molecular medicine
Published: November 21, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026